Get More Good with Zelapar

Benefits of ZELAPAR

ZELAPAR® (selegiline HCl) is a unique once-daily treatment for Parkinson's disease.

Effectiveness

As levodopa/carbidopa wearing off becomes more noticeable, the duration of good response (ON time) shortens, whereas the duration of poor response (OFF time) may lengthen. In a clinical trial, when ZELAPAR was added to levodopa/carbidopa treatment, patients with Parkinson's disease experienced:

Ease of use

Patient preferred

In one study, most patients preferred ZELAPAR ODT to their conventional selegiline tablets.

 

  • Meperidine or other selegiline products; 14 days should elapse between discontinuation of Zelapar and starting these therapies
  • Analgesic products tramadol, methadone, and propoxyphene
  • Cough suppressant dextromethorphan

How to Take Zelapar